Long-term use can lower vitamin B12 levels, so periodic B12 testing is reasonable
GLP-1s aren't yet FDA-approved for alcohol use disorder, and the evidence basewhile growingremains early-stage
Leroi I, Overshott R, Byrne EJ, Daniel E, Burns A
It depends on clinical stability, return of intestinal activity, lack of any event contraindicating, and a schedule for monitoring and recording
Weight loss from agents such as liraglutide produces further metabolic benefit: lower fasting glucose, reduced visceral fat, and better lipid profiles, all of which support improved fertility outcomes and lower pregnancy risk